Recent Updates
Recently added Catalysts

Upcoming Catalyst

Drug Pipeline Intelligence

Clinical Trial Results

Inside Trades

Options Data

News Section

Hedge Funds

Ownership Trends

Competitive Position

HealthStream Inc

$25.64

-0.36 (-1.38%)

Market Cap
583.60 M
EPS
0.61
P/E Ratio
32.7 $
Value Trade
6.74 M
SEC Financials
Q1 2026

  • Dilution Risk

    5%

  • Revenue

    81.20 M

  • R&D Expenses

    13.61 M

  • Operating CF

    27.14 M

  • Total Assets

    527.44 M

  • Total Liabilities

    527.44 M

  • Equity

    351.99 M

  • D/E Ratio

    12,345

%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Profitable

  • Cash Position

    66.50 M

  • Monthly Burn

    -

  • Runway

    12,345 mo

  • Burn Trend

    Stable

  • SEC Filing

    May 6, 2026
Overview
Volume
315.73 K
52 Week Range
19.50 - 34.13
% held by Insiders
20.72 %
% held by Institutions
74.49 %
Enterprise Value
544.18 M
Total Shares
29.68 M
Short %
4.17 %
Float Shares
23.54 M
Company Description
HQ: 500 11TH AVENUE NORTH, NASHVIL...
Employees:1,160
https://www.healthstream.com

locked

Upcoming Catalyst
Catalyst Drug/Treatment Stage Probability of Approval Description Drug Type Therapeutic Area Source
PDUFA 2026
Example Drug Treatment for example condition requiring FDA review
Phase 3
-%
Small Molecule
Oncology
Example Drug Treatment for example condition requiring FDA review
Phase 3
-%
Small Molecule
Oncology
Example Drug Treatment for example condition requiring FDA review
Phase 3
-%
Small Molecule
Oncology
Unlock Upcoming Catalyst data
Drug Pipeline Intelligence
Unlock Drug Pipeline Intelligence
Clinical Trial Results
Drug Name Indications Phase Date Trial Results Summary Title Source
Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01
Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01
Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01
Unlock Clinical Trial Results data
Inside Trades
TREND
CORPORATE INSIDERS BOUGHT SHARES WORTH 1.8M IN THE LAST 3 MONTHS
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Unlock Inside Trades data
Show Data
Hedge Funds
TREND
HEDGE FUNDS INCREASED HOLDINGS BY 200.0K SHARES IN THE LAST QUARTER
Shares Held
2040.00B1530.00B1020.00B510.00B0
Q3
2024
Q4
2024
Q1
2025
Q2
2025
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Fund Count
60%
Share Volume
25%
Conviction
15%
Hedge Funds invested in HSTM
HedgeFund Name
( 3 )
% of Portfolio Current MV
-
Shares Owned
-
Activity
Avg Price $0

Example Capital Management

2.5 %
15.00 M
250.00 K

Example Capital Management

2.5 %
15.00 M
250.00 K

Example Capital Management

2.5 %
15.00 M
250.00 K
Unlock Hedge Funds table data
HealthStream Inc (HSTM) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
HSTM
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
HSTM
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
HSTM
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
Unlock Biotech Analyst Ratings data
HSTM Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
Unlock Price Target Trend
HSTM Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
ExpirationVolumeOpen InterestImplied Volatility CallsImplied Volatility Puts
CallsPutsPut-Call RatioCallsPutsPut-Call RatioIVOiWaIvVWaIvIVOiWaIvVWaIv
2026-08-21 0.00 0 - - - - - -
2026-08-21 0.00 0 - - - - - -
2026-08-21 0.00 0 - - - - - -
Unlock Option Chain Statistics data
Option Chain
CallsStrikePuts
Last PriceVolumeOpen InterestLast PriceVolumeOpen Interest
No data available
Unlock Option Chain data
Unlock Options Chart data
Open interest
0 600K 1.2M 1.8M Avg OI 1.00 M Open Interest
0 1 2 3 1.1 Put-Call Ratio
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
0 450K 900K 1.4M Avg OV 750.00 K Option Volume
0 1 2 3 0.95 Put-Call Ratio
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-HSTM
May 4, 2026
HSTMGeneral

HealthStream Announces First Quarter 2026 Results

HealthStream has announced its financial results for the first quarter of 2026. The article provides limited information, primarily focusing on the announcement itself without detailed insights into the financial performance or future outlook.

Read more →
-HSTM
Apr 21, 2026
HSTMConferences/Events

HealthStream to Host First Quarter 2026 Earnings Conference Call

HealthStream, Inc. will host a conference call on May 5, 2026, to discuss its first quarter financial results for 2026. The results will be released after market close on May 4, 2026. Participants can join via webcast or telephone, with a replay available for 30 days. The announcement highlights HealthStream's commitment to transparency with investors.

Read more →
Competitive Position
How HSTM ranks across every disease it competes in
Competitive Position is a premium feature
See how HSTM ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial